Carlsmed Lands $52.5 Million in Series C
![Carlsmed Secures $52.5 Million in Series C Round](/content/images/size/w2000/auto/chatcmpl-949xBhwCd0UTt1a0Ox2LhDrUFG9Fc.jpeg)
Carlsmed, a medtech startup, has secured $52.5M in a Series C funding round led by B Capital, with participation from U.S. Venture Partners. This Carlsbad, CA-based company is expanding its AI-driven aprevo® platform for personalized spine surgery. Funds will bolster product development and market reach.